Updated on 19 September 2014
Potassium Chloride is indicated for treatment of potassium deficiency
Singapore: Global biopharmaceutical company, Baxter International, is recalling one lot of Potassium Chloride Injection 10mEq per 100mL, product code 2B0826, in US due to a labeling error on the shipping cartons.
According to the company, shipping cartons labeled for Potassium Chloride Injection may contain units of Gentamicin Sulfate Injection, 80 mg in 100 mL, product code 2B0862.
Potassium Chloride is indicated for treatment of potassium deficiency and administered intravenously and Gentamicin Sulfate is an antibacterial drug for intravenous administration.
As both products are packaged in 100mL containers, have similar code numbers and red labeling on the front panel, there is a potential risk of medication error or delay in therapy for patients that require high concentration potassium chloride.
The affected lot of Potassium Chloride Injection was distributed to customers in the United States between May 26, 2014, and August 8, 2014.